Oct 5, 2026 07:03AM
Oct 5, 2026 07:00AM
Sep 28, 2026 07:03AM
Sep 28, 2026 07:00AM
Sep 23, 2026 07:00AM
Sep 23, 2026 07:00AM
Sep 14, 2026 07:00AM Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
Aug 18, 2026 05:25PM
Aug 18, 2026 05:23PM
May 15, 2026 09:15AM
May 15, 2026 09:15AM
Apr 23, 2026 07:01AM
Apr 23, 2026 07:00AM
Apr 20, 2026 07:45AM Psyence BioMed reports GMP-compliant ibogaine inventory for research
Apr 20, 2026 07:42AM
Apr 20, 2026 07:42AM
Apr 17, 2026 09:15AM
Apr 8, 2026 09:15AM
Apr 8, 2026 09:15AM
Mar 11, 2026 09:15AM
Mar 3, 2026 09:16AM Psyence BioMed exports psilocybin to Australia for Phase IIb trial
Mar 3, 2026 09:15AM
Feb 20, 2026 05:20PM
Feb 17, 2026 09:15AM
Feb 13, 2026 06:30PM
Feb 11, 2026 09:17AM
Feb 11, 2026 09:15AM
Jan 28, 2026 06:30PM Psyence BioMed sets Feb. 2 effective date for reverse stock split
Jan 28, 2026 06:30PM
Jan 22, 2026 01:42PM
Jan 20, 2026 07:19AM
Jan 20, 2026 07:19AM
Jan 14, 2026 07:00PM
Jan 14, 2026 07:00PM
Jan 12, 2026 08:30AM Psyence BioMed authorizes share buyback program
Jan 12, 2026 08:30AM
Jan 5, 2026 09:15AM
Dec 19, 2025 07:01AM
Dec 19, 2025 07:00AM
Dec 9, 2025 07:00AM
Nov 25, 2025 07:05AM
Nov 25, 2025 07:00AM Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
Nov 20, 2025 07:01AM
Nov 20, 2025 07:00AM
Nov 12, 2025 07:00AM
Nov 12, 2025 07:00AM
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Nov 3, 2025 07:00AM Psyence BioMed invests $3.5 million in psychedelic supplier PsyLabs
Nov 3, 2025 07:00AM

333,525 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All